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INTRODUCTION
Mycobacterium tuberculosis is the causative agent of tuberculosis
(TB) and is responsible for about 1.6 million deaths annually (WHO:
http://www.who.int/tb/publications). Therefore, TB remains a
major global health problem and, despite renewed interest in this
ancient disease, we do not fully understand the exact mechanism
of mycobacterial virulence. Upon infection via inhalation of droplets
containing M. tuberculosis, bacteria are taken up by patrolling
alveolar macrophages. Even though the alveolar macrophages are
dedicated phagocytic cells with a range of antibacterial weapons,
pathogenic mycobacteria are able to persist and replicate in these
cells. The infected macrophages become activated and subsequently
recruit additional macrophages, neutrophils and lymphocytes.
Together, these cells form well organized, tight aggregates called
granulomas. These granulomas are the hallmark of tuberculosis
(Adams, 1976).
Because granuloma formation seems to be orchestrated by the
immune system, they have long been considered to be host
beneficial, and able to control bacterial replication and
dissemination (Saunders et al., 1999). However, various recent
studies imply that granuloma formation is also important for
bacterial survival and person-to-person spread. Bacteria inside
granulomas are able to prevent eradication by the immune system
and, moreover, aggregation of macrophages is in fact crucial for
mycobacterial dissemination (Volkman et al., 2004; Flynn and Chan,
2005; Kahnert et al., 2007; Davis and Ramakrishnan, 2009). In line
with this view, bacterial virulence factors have been identified that
promote the formation of granulomas (Volkman et al., 2004;
Swaim et al., 2006).
The most well studied genetic locus involved in mycobacterial
virulence and granuloma formation is probably region of difference
1 (RD1). This region, which spans nine genes, is deleted in all
attenuated Mycobacterium bovis bacille Calmette-Guérin (BCG)
vaccine strains (Mahairas et al., 1996). Reintroduction of an intact
version of RD1 into M. bovis BCG resulted in increased bacterial
growth and formation of granuloma-like structures in
immunodeficient mice (Pym et al., 2002), whereas deletion of RD1
from M. tuberculosis led to attenuation of both bacterial replication
and granuloma formation in a mouse infection model (Lewis et al.,
2003). Also Mycobacterium marinum, the causative agent of fish
tuberculosis, shows delayed granuloma formation in zebrafish
(Danio rerio) when RD1 is absent (Gao et al., 2004; Volkman et al.,
2004; Swaim et al., 2006). The nine genes of the RD1 region are
part of the ESX-1 locus, which encodes a specialized secretion
system responsible for the secretion of a number of proteins,
including the important virulence factors ESAT-6 and CFP-10.
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SUMMARY
The hallmark of tuberculosis (TB) is the formation of granulomas, which are clusters of infected macrophages surrounded by additional macrophages,
neutrophils and lymphocytes. Although it has long been thought that granulomas are beneficial for the host, there is evidence that mycobacteria
also promote the formation of these structures. In this study, we aimed to identify new mycobacterial factors involved in the initial stages of granuloma
formation. We exploited the zebrafish embryo Mycobacterium marinum infection model to study initiation of granuloma formation and developed
an in vivo screen to select for random M. marinum mutants that were unable to induce granuloma formation efficiently. Upon screening 200 mutants,
three mutants repeatedly initiated reduced granuloma formation. One of the mutants was found to be defective in the espL gene, which is located
in the ESX-1 cluster. The ESX-1 cluster is disrupted in the Mycobacterium bovis BCG vaccine strain and encodes a specialized secretion system known
to be important for granuloma formation and virulence. Although espL has not been implicated in protein secretion before, we observed a strong
effect on the secretion of the ESX-1 substrates ESAT-6 and EspE. We conclude that our zebrafish embryo M. marinum screen is a useful tool to identify
mycobacterial genes involved in the initial stages of granuloma formation and that we have identified a new component of the ESX-1 secretion
system. We are confident that our approach will contribute to the knowledge of mycobacterial virulence and could be helpful for the development
of new TB vaccines.
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These two secreted proteins are encoded by genes of the RD1
region. It has been reported that ESAT-6 is involved in the
disruption of membranes; consequently, the protein has been
associated with the translocation of mycobacteria from the
phagosome into the cytosol and subsequent intercellular spread
(Hsu et al., 2003; Gao et al., 2004; van der Wel et al., 2007; Smith
et al., 2008). These effector functions might explain the mechanism
of virulence of ESX-1.
Although ESX-1 is an important virulence factor of
mycobacteria, other factors will also be involved in virulence. Our
aim is to identify new mycobacterial virulence determinants, and
in particular bacterial factors involved in granuloma formation.
Because establishment of granulomas involves a complex
interaction between host and microbe, this objective requires an
in vivo approach.
In the past years, the M. marinum zebrafish model has been
established as a useful model for the study of mycobacterial
infections. M. marinum is a close genetic relative of M. tuberculosis
and, in ectotherms, causes a tuberculosis-like disease characterized
by granuloma formation (Ramakrishnan et al., 1997; Talaat et al.,
1998; Davis et al., 2002; Prouty et al., 2003; van der Sar et al., 2004;
Broussard and Ennis, 2007). The zebrafish is one of the natural hosts
of M. marinum, in which the pathogen produces caseating
granulomas that resemble human granulomas (Davis et al., 2002;
Prouty et al., 2003; van der Sar et al., 2004; Swaim et al., 2006). One
of the advantages of working with zebrafish is that their embryos
have not yet developed an adaptive immune system (Trede et al.,
2004), which enables the investigation of the role of the innate
immune response during mycobacterial disease separately from the
role of the adaptive system. Additionally, zebrafish embryos are
transparent, which makes it possible to follow early stages of M.
marinum infection in real-time. These early infection stages include
the formation of aggregates of infected macrophages. Interestingly,
it has been reported that M. marinum that is phagocytosed by
macrophages and is present within these aggregates induces the
upregulation of genes that were found to be specifically expressed
in mature granulomas (Davis et al., 2002). Therefore, the zebrafish
M. marinum model is an excellent model for studying
mycobacterial pathogenesis.
In this study, we have set up a screen to identify mycobacterial
genes involved in the onset of granuloma formation. We screened
a transposon mutant library of M. marinum in zebrafish embryos
for mutants with impaired initiation of granuloma formation. Upon
screening 200 mutants, we identified three mutants that repeatedly
induced less granuloma formation. In one of these mutants a
mutation in the ESX-1 region was found to be responsible for the
observed phenotype and ESAT-6 secretion was severely affected
in this mutant.
RESULTS
Screen for M. marinum mutants attenuated for granuloma
formation in zebrafish embryos
In order to detect mycobacterial factors involved in granuloma
formation, we used the well described zebrafish embryo M.
marinum infection model. Zebrafish embryos were injected into
the caudal vein (Fig. 1A) immediately after the onset of blood
circulation, i.e. at 28 hours post fertilization (hpf), with different
isolates of M. marinum expressing DsRed. To optimize the infection
model for granuloma formation, seven different M. marinum
strains were analyzed for their potential to initiate granulomas in
embryos. These strains were similar to those used in a previous
study involving adult zebrafish (van der Sar et al., 2004). Clustering
of macrophages infected with mycobacteria was used as an
indicator of initial granuloma formation, and was examined by
fluorescence microscopy at 5 days post infection (dpi). Although
all strains showed bacterial clustering, there was considerable
variability in the amount of initial granuloma formation (data not
shown). For further experiments, we selected strain E11 because
this isolate caused highly reproducible clustering of bacteria, at
inocula ranging from 50 to 200 colony forming units (CFUs) (Fig.
1B). Moreover, M. marinum strain E11 (also known as Mma11)
induces chronic infection with necrotizing granulomas in adult
zebrafish (van der Sar et al., 2004), which is also the case for
granulomas found in human TB patients.
To verify our granuloma model, it was important to determine
whether the aggregation of mycobacteria that we observed by
fluorescence microscopy actually represents early granuloma
formation. Therefore, we monitored the activity of an M. marinum
granuloma-activated promoter (gap) with a gap-eGFP construct as
was described previously (Ramakrishnan et al., 2000; Chan et al.,
2002; Davis et al., 2002). Because the gap promoter is specifically
active in granulomas and not in macrophages or in in vitro
conditions, expression of eGFP in aggregated mycobacteria
indicates granuloma-like conditions. Zebrafish embryos were
infected with Mma11 modified to constitutively express DsRed and
express eGFP under the control of gap7. At day 5 of infection we
observed that, in the clusters of red fluorescent mycobacteria, the
majority of the bacteria expressed eGFP (Fig. 1C). This
demonstrates that these mycobacteria encounter conditions that
are similar to those in mature granulomas.
Furthermore, to ensure the usability of this model for the
identification of early granuloma mutants, we investigated the
ability of a negative control to initiate granuloma formation. For
this experiment, we infected zebrafish embryos with an Mma11
mutant that has a mariner transposon insertion in gene eccCb1
(A.M.v.d.S., unpublished), one of the essential components of the
ESX-1 system (Stanley et al., 2003). As shown in Fig. 1D, bacterial
clustering was drastically reduced in the eccCb1::tn mutant at 5 dpi,
which indicates that our embryo model can indeed be used to
identify mutants in initial granuloma formation. The reduced
bacterial clustering of the eccCb1::tn mutant is consistent with a
previous study in which infection of zebrafish embryos with an ESX-
1 mutant in the M. marinum M strain resulted in reduced formation
of early granulomas (Volkman et al., 2004).
In order to analyze bacterial infection in a quantitative and
objective manner, two complementary methods were used. First,
fluorescent images of infected embryos were subjected to
automated analysis with software that was exclusively designed for
this purpose. Second, the amount of bacteria within infected
embryos was measured by plating whole embryos and counting
CFUs. According to the software program, the eccCb1::tn mutant
induces only 3.5% of the infection rate of wild-type bacteria (Fig.
1E). This number is highly comparable to the ratio of bacterial loads
of infected embryos as determined by plating (95.3 CFUs per
embryo for the eccCb1::tn mutant versus 1718 CFUs per embryo
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this automated analysis enables us to screen numerous mutants
simultaneously and to rapidly select for early-granuloma-deficient
mutants without any bias.
Having set up an early granuloma model, we screened a mariner
transposon library of Mma11 modified to constitutively express
DsRed. We performed mono-infections because co-infection with
multiple mutants can obscure the granuloma phenotype, owing to
the wild-type helper effect. Per mutant, a group of 15 embryos was
infected with approximately 100 CFUs and early granuloma
mutants were rescreened at least twice. Screening of the first
200 mutants resulted in the identification of three early granuloma
mutants, named FAM53, FAM58 and FAM67, that repeatedly
showed a reduced ability to induce granuloma formation (Fig. 2A-
C). The infection levels of embryos infected with the mutant strains
were 20-46% of the parental Mma11 infection level (Fig. 2D).
Early granuloma mutants are not essentially defective for
intracellular growth or spread
The aim of this screen was to identify mutants that are specifically
attenuated for granuloma formation in vivo. However, it would also
probably identify mutants deficient in survival in macrophages or
dissemination to uninfected macrophages. In order to differentiate
between these two classes of mutants, we performed in vitro
infection experiments. Because macrophages are the primary cells
for intracellular growth of mycobacteria during disease, we used
the human monocytic cell line THP1 in our in vitro experiments.
Activated THP1 cells were infected for 2 hours with the different
early granuloma mutants at a multiplicity of infection (MOI) of 1.
At 0, 24, 48 and 72 hours post infection (hpi), intracellular growth
and spread of the bacteria were examined.
CFU counting of THP1 cell lysates indicated that none of the early
granuloma mutants has a severe replication defect in host cells (Fig.
3A). Only mutant FAM58 displayed a moderate decrease in growth.
By contrast, intracellular replication of the Mma11 eccCb1::tn mutant
was drastically reduced as compared with that of the wild-type strain
(Fig. 3A). This variation in intracellular growth was specific for
infected cells, because all mutants demonstrated broadly comparable
growth rates in liquid culture (Fig. 3B).
In order to assay intercellular spread of the mutants, the
percentage of infected THP1 cells was examined by fluorescence
microscopy. At 48 hpi, the percentage of THP1 cells infected with
wild-type M. marinum reached approximately 100% (Fig. 3C).
Consistent with the CFU experiments, FAM53 and FAM67
disseminated equally well. In marked contrast to the parental
Mma11 strain, intercellular spread of the eccCb1::tn mutant was
strongly attenuated. In THP1 cells infected with mutant FAM58,
an intermediate level of bacterial dissemination was observed (Fig.
3C).
Fig. 1. Initiation of granuloma formation in M. marinum E11 (Mma11)-infected embryos. (A)Overview of a zebrafish embryo at 28 hpf. The arrow indicates the
caudal vein injection site used in this study. (B)Embryo 5 days after infection with 110 CFUs Mma11. Overlay of brightfield and fluorescent images is shown.
Aggregates of red fluorescent bacteria are seen in the tail and head region. Scale bar: 500m. (C)Bacterial clustering in tail at 5 dpi with 92 CFUs Mma11
expressing hsp::DsRed and gap7::eGFP. Of the total amount of bacteria [constitutively expressing red fluorescence (top panel)], the majority expresses eGFP
(middle panel), indicating that the bacteria reside in clusters that resemble granulomas. Overlay shows overlapping red and green fluorescence as yellow (bottom
panel). Scale bar: 50m. (D)The Mma11 eccCb1::tn mutant is highly attenuated for initiation of granuloma formation at 5 dpi with 171 CFUs. Loose spots of red
fluorescent bacteria are detected, but aggregates are not found. Scale bar: 500m. (E)Quantification of infection as determined with specially designed software.
The amount of red (fluorescent) pixels of fluorescent images of embryos infected with the eccCb1::tn mutant is set as a percentage of the amount of red pixels of
fluorescent images of embryos infected with wild-type bacteria (WT). Data shown are mean + standard deviation of three independent experiments (***P<0.001,
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Altogether, these results indicate that two of the three early
granuloma mutants are not defective for intracellular growth and
spread. This means that our screen is able to identify genes that
are specifically required for the onset of granuloma formation in
vivo and, consequently, that our screen has an added value as
compared with a macrophage screen.
Identification of genes involved in the initial steps of granuloma
formation
In order to identify the genes that were mutated in the three early
granuloma mutants, the transposon insertion sites were determined
by ligation-mediated PCR and sequence analysis.
The mariner transposon of mutant FAM53 is inserted in fadE33,
which encodes a probable acyl-CoA dehydrogenase. This gene is
highly conserved among actinobacteria and has a predicted
function in lipid degradation. To analyze whether this mutation
has any effect on the lipid and mycolic acid content of M. marinum,
thin layer chromatography was performed using various systems
according to previously described protocols (Besra, 1998). No
differences between wild-type and mutant FAM53 were observed
either in terms of mycolic acid profiles, extractable apolar lipid
systems A-D, and polar lipid systems D and E (data not shown).
These results indicate that the observed granuloma-deficient
phenotype is probably not due to an alteration of cell wall lipids in
the FAM53 mutant.
As mentioned previously, ESX-1 mutants are known to be
delayed in granuloma formation (Gao et al., 2004; Volkman et al.,
2004). Therefore, we expected to identify ESX-1 mutants in our in
vivo granuloma screen. Mutant FAM58 indeed has a transposon
insertion in the ESX-1 cluster, although the transposon is not
inserted in one of the known ESX-1 genes. The exact insertion site
of the mariner transposon is ten base pairs upstream of the gene
espL (mmar_5456) and 27 base pairs downstream of espB
(mmar_5457). Both expression and secretion of EspB were not
impaired in mutant FAM58, as was determined by an immunoblot
with an antibody directed against EspB of M. tuberculosis (Fig. 4A).
Next, quantitative reverse-transcriptase (RT)-PCR was performed
on Mma11 wild-type and mutant FAM58 to analyze transcription
levels of espL and espB (Fig. 4B). As a control, the level of eccCb1
transcripts was determined using primers surrounding the
transposon insertion site of the eccCb1::tn mutant. As expected,
similar eccCb1 transcription levels were observed in M. marinum
wild-type and mutant FAM58, whereas eccCb1 transcripts were
not detected in the eccCb1::tn mutant. In agreement with the
immunoblot results, no drastic differences were observed between
wild-type and mutant FAM58 espB transcripts. By contrast,
Fig. 2. Three out of 200 transposon mutants were identified as early
granuloma mutants. Infection of embryos with mutants FAM53, FAM58 and
FAM67 reproducibly resulted in either smaller or fewer early granulomas at 5
dpi, as compared with the wild type (see Fig. 1B). (A-C)Representative overlays
of brightfield and fluorescent images of embryos infected with 71 CFUs of
mutant FAM53 (A), 70 CFUs of mutant FAM58 (B) and 86 CFUs of mutant
FAM67 (C) are shown. Scale bars: 500m. (D)Relative levels of infection
determined by automated quantification of fluorescent pixels. The results
represent mean + standard deviation of all experiments performed (n3 to 9)
(*P<0.029, ***P<0.001, unpaired Student’s t-test).
Fig. 3. Intracellular growth and spread of early granuloma mutants.
(A)Intracellular growth of M. marinum in THP1 cells. THP1 macrophage-like
cells were infected at MOI 1 with wild-type Mma11 (WT), the eccCb1::tn
mutant and the three early granuloma mutants. The number of CFUs was
determined by lysing infected THP1 cells and plating lysates at the indicated
time points. Figure shows mean ± standard deviation for three independent
experiments. (B)Growth rate of bacteria in 7H9 medium. Results represent
mean ± standard deviation of two independent replicates. (C)Intercellular
spread of M. marinum in THP1 cells. THP1 cells were infected at MOI 1 with
wild-type Mma11 (WT), the eccCb1::tn mutant and the three early granuloma
mutants. Percentage of infected cells was determined by microscopic
enumeration of bacilli within THP1 cells. Mean + standard deviation of two
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transcription levels of espL were significantly reduced in mutant
FAM58 (0.02 versus 1 – a 50-fold reduction). Therefore, we
conclude that defective transcription of espL probably accounts for
the early-granuloma-deficient phenotype.
Mutant FAM67 has a genetic link with the ESX-1 cluster as well.
In this mutant, the transposon is also located in an intergenic region,
the exact site being 19 base pairs downstream of gene mmar_5425
and 364 base pairs downstream of mmar_5426. Interestingly,
although mmar_5425 is not located in the ESX-1 region itself, it
shares homology with the ESX-1 gene espK. Furthermore, the
transposon is inserted in a genomic region of 22 genes that is
located immediately upstream of the ESX-1 locus and is specific
for M. marinum. Out of these 22 genes, 20 are homologous to ESX-
1 or ESX-1-associated genes (Stinear et al., 2008).
ESX-1 secretion of early granuloma mutants
The ESX-1 locus encodes a specialized secretion system responsible
for the secretion of multiple proteins, including ESAT-6. ESAT-6
is an important mycobacterial virulence factor that is involved in
phagosomal escape, cell lysis and cell-to-cell spread (Hsu et al., 2003;
Gao et al., 2004; van der Wel et al., 2007; Smith et al., 2008).
Furthermore, the reduction of expression and secretion of ESAT-
6 is associated with delayed granuloma formation in both M.
tuberculosis and M. marinum (Pym et al., 2002; Lewis et al., 2003;
Volkman et al., 2004). Because mutant FAM58 was mutated in the
ESX-1 region and also mutant FAM67 has a genetic link with ESX-
1, for all three early granuloma mutants we analyzed expression
and secretion of ESAT-6 and EspE, an ESX-1 secreted protein that
is partially cell wall associated (Carlsson et al., 2009; Sani et al.,
2010) (Fig. 5). In these experiments, we used GroEL2 as a marker
for fractionation. As a negative control, the M. marinum eccCb1::tn
mutant was used, which is known to be defective for ESX-1
secretion. As shown in Fig. 5A, ESAT-6 was detected in pellet
fractions of wild-type Mma11 and all mutant bacteria, although in
mutant FAM58 the protein was produced in slightly lower amounts.
Interestingly, ESAT-6 secretion was strongly reduced in mutant
FAM58, although secretion was not completely inhibited as it was
for the eccCb1::tn mutant. This might be due to the fact that mutant
FAM58 is not disrupted in one of the core components of the ESX-
1 machinery, as is the case with mutant eccCb1::tn, but in an putative
ESX-1 accessory gene, espL. It is known that ESAT-6 secretion is
not only dependent on core components of the ESX-1 secretion
system, but also on multiple ESX-1 substrates (Fortune et al., 2005;
McLaughlin et al., 2007; Xu et al., 2007). We hypothesize that the
residual ESAT-6 secretion of the FAM58 mutant contributes to the
difference in infection level (20% versus 3.5%; compare Fig. 2D with
Fig. 1E). Strikingly, although EspE was expressed intracellularly by
the eccCb1::tn mutant, EspE could not be detected in any of the
FAM58 fractions (Fig. 5B). In order to further investigate the nature
of defective EspE expression in mutant FAM58, we analyzed espE
transcription levels by quantitative RT-PCR. As shown in Fig. 4B,
transcripts of espE in mutant FAM58 were moderately reduced as
compared with those in wild type. However, transcription levels of
espE in the eccCb1::tn mutant were even further decreased. These
results demonstrate that EspL is not involved in the transcriptional
regulation of espE and indicate that EspL might be required for the
stability of this ESX-1 substrate.
Fig. 4. Transcript levels of espL are strongly decreased in the FAM58
mutant. (A)Equivalent amounts of bacterial pellet (P) and culture supernatant
(S) fractions of wild-type Mma11 and mutant FAM58 were separated on SDS-
PAGE, immunoblotted and incubated with an antibody directed against EspB.
As a fractionation control, the cytosolic protein GroEL2 was analyzed. (B)espL
and espB transcription levels were analyzed for mutant FAM58, mutant FAM58
complemented with either espL (C58a) or the espL-espB operon (C58b) by
quantitative RT-PCR and compared with wild-type Mma11 and the eccCb1::tn
mutant. Additionally, transcript levels of espE and eccCb1 were measured.
Transcription levels were normalized to sigA because it has previously been
shown that sigA mRNA levels remain unchanged during various growth
conditions. Transcript levels of mutants and complemented mutants are
presented as relative values compared with wild-type levels. Data shown are
mean + standard deviation for three independent replicates.
Fig. 5. ESX-1 secretion is affected in the FAM58 mutant.
Equivalent amounts of bacterial cell pellet (P) and supernatant (S)
fractions of the three early granuloma mutants and mutant FAM58
complemented with either espL (C58a) or the espL-espB operon
(C58b) were analyzed for the presence of the ESX-1 substrates
ESAT-6 (A) and EspE (B) by SDS-PAGE separation and immunoblot,
and compared with those of wild-type Mma11 and the eccCb1::tn
mutant. For immunoblots with anti-EspE antibodies, in addition to
pellet and supernatant samples, extracted cell wall fractions (CW)
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Complementation of early-granuloma-deficient phenotype
To determine the genetic requirements for recovery of the early-
granuloma-forming phenotype, mutant FAM58 was complemented
with the intact version of espL or the espL-espB operon.
Introduction of an integrative plasmid containing espL in mutant
FAM58 (C58a) had only a slight effect on the mutant phenotype,
i.e. onset of granuloma formation (Fig. 6C,E) and ESAT-6 secretion
(Fig. 5A). These small changes might be explained by the fact that
espL transcript levels are only marginally increased in this
complemented mutant (see Fig. 4B; 0.04 versus 0.02 for mutant
FAM58). For mutant FAM58 containing the entire espL-espB
operon on an integrative plasmid (C58b), espL transcription levels
were considerably increased, which probably resulted in increased
initial granuloma formation (Fig. 6D,E) and ESAT-6 secretion (Fig.
5A), although none of these parameters reached wild-type levels.
Surprisingly, although EspE expression was rescued in C58b, the
protein was not detectable in the cell wall fraction (Fig. 5B). Our
complementation experiments indicate that EspL is a newly
identified ESX-1 component involved in ESAT-6 secretion and
stable EspE expression.
DISCUSSION
Granuloma formation is a hallmark of tuberculosis and over recent
years it has become clear that mycobacteria actively promote the
organization of these structures (Cosma et al., 2004; Volkman et
al., 2004; Kahnert et al., 2007). However, thus far, bacterial factors
that are involved in this process remain largely unknown. In this
study, we have set up and demonstrated the use of a zebrafish
embryo screen for the identification of bacterial genes involved in
the initiation of mycobacterial granuloma formation. In order to
find mycobacterial genes involved in the onset of granuloma
formation, we analyzed 200 mutants from a random transposon
mutant library of M. marinum. Although this number represents
approximately merely 3% of the M. marinum genome, we identified
three mutants that were reproducibly attenuated for early
granuloma formation. None of these three mutants showed severely
impaired replication in macrophages, and intercellular spread was
only reduced in mutant FAM58. Apparently, granuloma formation
goes beyond bacterial persistence in macrophages. This is not
surprising, given that the development of a complex structure, such
as a granuloma, depends on complicated processes involved in the
recruitment and activation of immune cells. Moreover, the
conditions experienced by mycobacteria inside granulomas are
highly different as compared with those in macrophages (Chan et
al., 2002). Therefore, we conclude that our in vivo approach for the
identification of factors involved in the initiation of granuloma
formation is an important tool to understand this complicated
process.
One of the genes identified in this screen is fadE33, which is
proposed to play a role in lipid metabolism. Mycobacteria have a
unique cell envelope with an extraordinary high lipid content (Daffe
and Draper, 1998). This outermost component of the bacteria
contributes to their low permeability and resistance to many toxic
compounds, and is involved in important host-pathogen
interactions (Brennan and Nikaido, 1995; Karakousis et al., 2004).
Furthermore, within granulomas mycobacteria adapt by switching
from carbohydrate to fatty acid metabolism (Bishai, 2000). Thin-
layer chromatography results did not demonstrate any
dissimilarities in lipid contents of the cell wall between mutant
FAM53 and wild-type bacteria. This indicates that attenuation of
the FAM53 mutant is probably not due to an alteration of the cell
envelope, so it might be that a metabolic defect is responsible for
the reduced initiation of granuloma formation. This hypothesis is
supported by the fact that fadE33 is located in a genomic region
with numerous genes that also have a predicted function in lipid
catabolism.
The ESX-1 secretion system plays an important role in
mycobacterial virulence and is studied extensively. Although the
exact mechanism of attenuation is not known, it has been
demonstrated that deletions of ESX-1 core components or
substrates are associated with defects in phagosomal maturation
arrest, membranolytic capacity, phagosomal escape, intracellular
replication, intercellular spread and granuloma formation in mice
and zebrafish (Hsu et al., 2003; Stanley et al., 2003; Gao et al., 2004;
Guinn et al., 2004; Volkman et al., 2004; Tan et al., 2006; van der
Fig. 6. Complementation of early granuloma mutant FAM58. Embryos
5 days after infection with wild-type Mma11, mutant FAM58 and FAM58
carrying a plasmid for expression of espL (C58a) or the espL-espB operon
(C58b). (A-D)Representative images of embryos for all experiments performed
(n4 to 9) are shown. Infection doses were 137 CFUs for wild-type Mma11 (A),
128 CFUs for mutant FAM58 (B), 171 CFUs for C58a (C) and 127 CFUs for C58b
(D). Scale bars: 500m. (E)Automated quantification of relative infection level.
Results represent mean + standard deviation for all experiments performed
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Wel et al., 2007; Smith et al., 2008). So, it is not surprising that we
have identified two mutants that have a link with ESX-1. Actually,
the fact that ESX-1 mutations were picked up supports the reliability
of our screen. It is, however, intriguing that the two ESX-1-
associated genes that we found have not been associated with
virulence before.
The gene that is mutated in FAM67, mmar_5425, is located in an
M. marinum specific region encompassing 22 genes directly
upstream of the ESX-1 region (Stinear et al., 2008). Except for one,
all of these genes are homologous to ESX-1 genes. Strikingly, 13 of
the 22 genes encode homologues of EspA, a protein that is secreted
by the ESX-1 system. EspA is necessary for ESAT-6 and CFP-10
secretion and for virulence in mice (Fortune et al., 2005; Garces et
al., 2010). The extended ESX-1 locus of M. marinum indicates that
this organism has a large repertoire of putative ESX-1 substrates that
might be involved in virulence and granuloma formation.
Mmar_5425 is highly similar to the N-terminal region of the ESX-
1 gene espK. The exact role of EspK in virulence is not completely
clear and deletion of its gene in M. bovis had no effect on virulence
in a guinea pig infection model (Inwald et al., 2003). By contrast, an
M. marinum mutant of espK was defective for ESAT-6 secretion and
showed decreased cytolysis and cell spread in vitro (Gao et al., 2004).
In contrast to the espK mutant, FAM67 did not have a defect in ESAT-
6 secretion. Furthermore, FAM67 was not attenuated for either
growth or spread in macrophages. Although the function of
mmar_5425 remains to be determined, we hypothesize that ESX-1
contributes to granuloma formation not only by ESAT-6 secretion,
but also via additional mechanisms induced by other secreted
proteins.
The second ESX-1-related gene that we identified, mmar_5456
or espL, did have an effect on ESAT-6 secretion. We have
demonstrated that espL is required for dissemination to
macrophages, which is in line with a very recently published paper
demonstrating that phagosomal maturation arrest in macrophages
is affected in an M. tuberculosis espL mutant (Brodin et al., 2010).
We expect that the lack of effective ESAT-6 secretion is responsible
for the defective intercellular spread and, consequently, the limited
onset of granuloma formation of the FAM58 mutant. Strikingly,
the mutation in FAM58 also resulted in reduced expression or
stability of EspE. Our results indicate that EspL is a new ESX-1
component important for expression and secretion of multiple
ESX-1 substrates. These findings contribute to the complexity
of ESX-1-dependent secretion, and emphasize the important role
of ESX-1 in granuloma formation and virulence.
This study has demonstrated that our approach to screen for
initial granuloma formation mutants with the zebrafish embryo M.
marinum model results in the identification of interesting new
virulence factors of mycobacteria. It is promising that screening of
a relatively small amount of bacterial mutants identifies a number
of exciting new virulence determinants. The ability to investigate
our pathogen of interest in a natural host in an in vivo system
contributes considerably to the strength of our approach. Our study
adds to the understanding of currently known virulence
determinants, such as ESX-1, but is also able to identify unknown
virulence factors. These kinds of powerful in vivo screens will help
to create new possibilities for the development of antibiotics, and
mutants identified with such a screen might be potential new
tuberculosis vaccines.
METHODS
Bacterial strains and growth conditions
Seven different M. marinum strains were used in this study. Two
of them were fish isolates: strain E11 and E7 (Puttinaowarat et al.,
1999). Strain 420472-4 was isolated from an infected snake and
strain M, 9800607, 2000-01053 and 2001-00796 were originally
isolated from human patients with fish tank granulomas
(Ramakrishnan and Falkow, 1994; van der Sar et al., 2004). The M.
marinum strains were grown at 30°C in Middlebrook 7H9 broth
(Difco) with 10% Middlebrook albumin-dextrose-catalase (ADC;
BD Bioscience) and 0.05% Tween-80 or on Middlebrook 7H10 agar
(Difco) supplemented with 10% oleic-acid-albumin-dextrose-
catalase (OADC; BD Bioscience). If M. marinum was cultured for
electroporation, 2.5 mg/ml glycine was added once the cultures
reached an optical density at 600 nm (OD600) between 0.5 and 0.8
in order to increase electroporation efficiency. For secretion
experiments, 7H9 medium supplemented with 0.04% ADC and
0.2% (w/v) dextrose was used. For cloning procedures, the
Escherichia coli strain DH5 was used.
Plasmid transformation and transposon mutagenesis
The mycobacterial shuttle vector pSMT3-DsRed was constructed
as a derivate of the pSMT3-eGFP vector (Hayward et al., 1999).
The vector pSMT3-eGFP was digested with BamHI and EcoRV to
remove the gene encoding eGFP, which was replaced by a gene
encoding DsRed that was excised as a BamHI-PvuII fragment from
pGMDs3 (van der Sar et al., 2003). pSMT3-DsRed was
electroporated into the Mma11 strain in order to be able to
visualize bacteria. Transformants were selected on plates with
50  g/ml hygromycin. Next, a transposon mutant library of
Mma11  containing pSMT3-DsRed was generated with phage
phiMycoMarT7, which contains the mariner-derived transposon
Himar1 (Sassetti et al., 2001). It has been determined that
transposition of the mariner transposon is random, and requires
only the dinucleotide TA (Rubin et al., 1999). To select for
transposon mutants, bacteria were grown on 7H10 plates
supplemented with 50 g/ml hygromycin and 25 g/ml kanamycin.
Granuloma-activated promoter construct
The plasmid pSMT3-DsRed with the gap7-eGFP fusion was created
by cloning a SpeI fragment that consists of the gap7-eGFP fusion
and the kanamycin cassette of the gap7 construct (Chan et al., 2002)
into the XbaI site of the pSMT3-DsRed vector.
Mutant screen for initial granuloma formation in zebrafish
embryos
Transposon mutant bacteria were grown until logarithmic phase,
washed with 0.3% Tween-80 in phosphate buffered saline (PBS) to
declump the bacteria, and resuspended in PBS containing 0.17%
phenol red (Sigma) to aid visualization of the injection process.
Wild-type D. rerio embryos at 28 hpf were dechorionated and
infected by microinjection in the caudal vein. A total of 15 embryos
were inoculated per mutant. To determine the exact number of
bacteria injected into the embryos, the injection volume was also
plated on 7H10 plates. Embryos were kept at 28°C in egg water
(60 g/ml instant ocean see salts) with 0.003% (w/v) 1-phenyl-2-
thiourea (Sigma) to prevent melanization. At 5 dpi, bacterial
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Microscope. Brightfield and fluorescence images were generated
with a Leica DC500 (DFC420C) camera, and early granuloma
formation was analyzed visually and quantified with dedicated
software (see below). During injection and microscopic examining,
embryos were anesthetized in egg water with 0.02% (w/v) ethyl-3-
aminobenzoate methanesulfonate salt (Sigma). All procedures
involving zebrafish embryos were performed in compliance with
local animal welfare laws.
Quantification of infection level
In order to quantify bacterial loads, fluorescent images of the
infected zebrafish embryos were analyzed with specially designed,
dedicated software (A.E.N., unpublished). For the analysis, three
types of images were distinguished. First, fluorescent images of
uninfected embryos were used. From these images, the average
background intensity in each experimental run could be established.
Second, as reference images, fluorescent images of embryos infected
with wild-type bacteria were analyzed. Each reference image was
thresholded by the background value obtained from the images of
uninfected embryos. Per image, the sum of the pixels from the
fluorescent red channel above background intensity was divided
by the number of embryos. This was done for all images within a
group and provides us a reference value of the amount of red
fluorescent pixels per embryo at wild-type infection level. For each
group of images of zebrafish embryos infected with mutant bacteria,
the same calculation as for the reference images was realized and
subsequently, the amount of fluorescent red pixels was provided
as a percentage of the wild-type level.
Results are written to a comma separated file so that further
statistical analysis and classification can be applied to the data. The
measurement software was written in Delphi. The Graphical User
Interface (GUI), written in English, allows for quick selection of
experimental files and setup data files; it includes functions for folder
processing and basic image manipulation. The actual processing is
fully automated, which is very convenient in the medium-
throughput context in which the experiments were realized.
Different algorithms can be included in this processing environment
so as to compare efficiency and precision of the algorithms
(Nezhinsky and Verbeek, 2010) (for additional information, see
http://bio-imaging.liacs.nl/galleries/ granulomaload/).
Determination of bacterial loads of infected embryos
Pools of three embryos were dissociated in microcentrifuge tubes
containing 100 l 5% SDS in PBS. By incubation with 100 l
MycoPrep reagent (BD Bioscience; BBL 240862) for 10 minutes,
under constant shaking, cells were lysed and decontaminated. To
neutralize the solution, 1.8 ml of PBS was added and the
homogenates were centrifuged for 15 minutes at 16,000 g. 1.9 ml
supernatant was removed and serial dilutions were plated on 7H10
plates.
THP1 infection assay
The human acute monocytic leukemia cell line THP1 was
maintained on RPMI 1640 medium (Gibco) supplemented with 10%
fetal calf serum (FCS), penicillin (100 units/ml) and streptomycin
(100 g/ml) at 37°C and 5% CO2. Infection experiments with THP1
cells were carried out in 24-well plates. Cells were harvested by
centrifugation for 10 minutes at 200 g and the pellet was
resuspended in RPMI 1640 supplemented with FCS, penicillin and
streptomycin to a density of approximately 3105 cells/ml. In order
to differentiate the THP1 cells into macrophage-like cells, 10
ng/ml phorbol myristate acetate was added and 1 ml of cell
suspension was added to each well of a 24-well plate. For
microscopy, THP1 cells were seeded on glass slides in 24-well plates.
Plates were incubated overnight at 37°C and 5% CO2. Medium was
replaced by RPMI 1640 supplemented with FCS and plates were
incubated overnight. For THP1 infection, bacteria were harvested
by centrifugation for 10 minutes at 16,000 g, washed with RPMI
1640 and suspended in RPMI 1640 with FCS. Bacteria were added
to the cells at a multiplicity of infection of 1 and the cells were
incubated for 2 hours at 30°C. Infected THP1 cells were washed
three times with RPMI medium to remove extracellular bacteria
and incubated in fresh RPMI with FCS for the indicated time points.
To determine the amount of CFUs, cells were lysed by a 10-minute
incubation with 1% Triton X-100 in PBS and bacteria were
quantified by plating serial dilutions of lysates on 7H10 plates. For
microscopic analysis, cells on glass slides were fixed with 4%
paraformaldehyde for 24 hours, washed, mounted in
VECTASHIELD (Vector Laboratories) and analyzed with a ZEISS
Axioskop 40 microscope.
Identification of mutated genes
The transposon insertion sites of the early granuloma mutants were
determined by ligation-mediated PCR as previously described
(Abdallah et al., 2006). In addition to BamHI-BglII digestion,
chromosomal DNA was separately also digested with PspOMI. For
this restriction, the ligated linker consisted of the annealed
oligonucleotides SalgD and PsPPT2 (for sequences see
supplementary material Table S1). Furthermore, the mycomar T7-
pr1 primer (supplementary material Table S1), located on the
transposon, was also used in the PCR reaction.
SDS-PAGE and immunoblots
Mycobacterial cultures were grown to an OD600~1. Pellet and
supernatant fraction were separated by centrifugation. Bacterial
cells were resuspended in PBS and subjected to bead-beating
(Biospec) with glass beads (Sigma). Secreted proteins were
precipitated from supernatant fractions with 10% (w/v)
trichloroacetic acid (TCA). Samples were normalized to total
protein concentration of the pellet fractions as determined by BCA
Protein Assay (Pierce), mixed with SDS–polyacrylamide-gel-
electrophoresis (SDS-PAGE) buffer, boiled for 10 minutes and
separated by SDS-PAGE on 18% polyacrylamide gels for ESAT-6
and 12% gels for GroEL2. Proteins were visualized by
immunoblotting with antibodies directed against ESAT-6 (Mab
Hyb76-8) and GroEL2 (CS44; John Belisle, NIH, Bethesda, MD,
contract No. AI-75320). The second antibody, GAMPO (American
Qualex), was detected with enhanced chemiluminescence (ECL)
using West Dura reagent (Pierce). For EspE analysis, prior to lysing
pellet fractions, proteins were extracted from the cell wall by
incubating pelleted bacterial cells with 0.5% Genapol X-080 in PBS
for 30 minutes at room temperature. Extracted fractions were
separated from bacterial cells by centrifugation and concentrated
by TCA precipitation. Protein samples were prepared as described
above and separated on 12% polyacrylamide gels. Proteins were















    




Mycobacterial granuloma mutant screenRESEARCH ARTICLE
antibody, GARPO (Rockland), was detected with ECL. For
immunoblots with anti-EspB antibodies, 500 ml bacterial cultures
were grown to OD600~0.7, after which bacterial pellets were washed
with 7H9 medium supplemented with 0.2% (w/v) dextrose and
resuspended in 500 ml of 7H9 with 0.2% (w/v) dextrose to grow
overnight. Bacterial cells were harvested by centrifugation and pellet
samples were prepared as described above. Supernatants were
filtered through a 0.22 m pore-size filter and concentrated with an
ultra-filtration cell (Amicon; model 202) with a 3000 Da molecular
mass cut-off membrane (Millipore). Concentrated supernatant
protein samples were prepared as described above and samples were
run on 10% gels. Proteins were detected with anti-EspB antibodies.
The presence of the secondary antibody, peroxidase-labeled rabbit
anti-rat-immunoglobulin, was visualized by ECL.
RNA isolation and quantitative RT-PCR
RNA was purified from bacterial cultures grown to an OD600~1.
Bacterial cells were disrupted by bead-beating in the presence of
TRIzol Reagent (Invitrogen), and RNA was isolated according to
the manufacturer’s instructions. To eliminate genomic DNA
contamination, RNA samples were treated with DNase I
(Fermentas) and further purified with the RNeasy mini kit (Qiagen).
cDNA was synthesized from 400 ng total RNA with the SuperScript
VILO cDNA synthesis kit (Invitrogen), according to the protocol
supplied by the manufacturer. Prior to use in subsequent PCR
reactions, cDNA was diluted 1:10 and 1:100. Reactions were set
up using EXPRESS SYBR GreenER qPCR SuperMix Universal
(Invitrogen) and quantitative RT-PCR was performed with the
LightCycler 480 Real-Time PCR System (Roche). Primers are listed
in supplementary material Table S1. Data were normalized to the
housekeeping gene sigA, which was used as an endogenous control
(Manganelli et al., 2004).
Complementation of the mutants
The genes or gene regions in which transposons were inserted were
PCR amplified with proofreading Pfu DNA Polymerase (Fermentas)
using wild-type Mma11 genomic DNA as template. The
oligonucleotides used to amplify espL and the espL-espB operon
were esmm5456-F in combination with esmm5456-R or
esmm5457-R (see supplementary material Table S1 for sequences).
PCR products were cloned into the pJET1.2 cloning vector
(Fermentas). To create an integrative vector, we used the pUC-INT-
CAT vector (Abdallah et al., 2009). From this vector, we used a
HindIII restriction fragment bearing the CAT cassette, the attP site
and the integrase gene, and ligated this fragment into the HindIII
site of the pJET vector that contained espL or the espL-espB operon.
The resulting plasmid is an integrative, chloramphenicol-resistant
vector. Plasmids were electroporated into the corresponding
mutants and plated on 7H10 agar plates containing 50 g/ml
hygromycin and 30 g/ml chloramphenicol. To confirm correct
genome insertion, a PCR was performed with primers surrounding
the integration site; wbINTgen and wbINTpls (see supplementary
material Table S1), and with primers specific for the inserted genes.
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TRANSLATIONAL IMPACT
Clinical issue
About 1.6 million people a year still die from tuberculosis (TB), and the disease
is a major unresolved global health problem. The causative agent of TB is the
bacterium Mycobacterium tuberculosis, which infects alveolar macrophages
when it is inhaled as an aerosol. Macrophages are activated upon being
infected, and recruit other macrophages, neutrophils and lymphocytes to
cause the characteristic granulomas, or tubercles, that are the hallmark of TB.
Granulomas are a double-edged sword: on the one hand they prevent the
spread of M. tuberculosis throughout the body, but on the other hand they
permit local multiplication of the bacteria and cause tissue destruction,
thereby favouring transmission of the tubercle bacillus. In recent years, it has
become clear that mycobacteria encode virulence factors that actively
promote the formation of granulomas. These factors are of great interest both
as targets for new anti-TB therapeutics, and also for developing new vaccine
strains that are attenuated for granuloma formation. 
Most studies that aim to identify tuberculosis virulence determinants are
performed in vitro but, because formation of granulomas requires complicated
host-pathogen interactions, this characteristic is best studied in vivo. The
zebrafish (Danio rerio) is a useful model to study mycobacterial infections,
because it is the natural host of Mycobacterium marinum – a close genetic
relative of M. tuberculosis – which causes a tuberculosis-like disease
characterized by necrotic caseating (‘cheese-like’) granulomas similar to those
seen in infected humans.
Results 
This study describes the development of a genetic screen for virulence factors
involved in granuloma formation in zebrafish. A library of 200 single gene
mutants of M. marinum bacteria, made by random insertion of the mariner
transposable element into the M. marinum genome, is used to infect embryos.
Mutants are scored for their effects on early granuloma formation by
quantifying clusters of bacteria expressing DsRed.
Using this screen, three mutants are isolated as potential novel virulence
factors, two of which are linked to the ESX-1 secretion system, a key player in
the initiation of granuloma formation. One of the genes, espL, is located within
the ESX-1 gene cluster, and its disruption has a strongly negative effect on
secretion of the ESX-1 substrates ESAT-6 and EspE. 
Implications and future directions
This work describes a novel medium-throughput in vivo screen to analyze the
molecular mechanisms involved in early granuloma formation. As an
experimental tool, the approach has many advantages. Screening of even a
small sample of mutants can result in the identification of novel virulence
factors and, because zebrafish embryos are easy to obtain and handle,
infections can be performed within a short period of 6 days. Many transgenic
zebrafish lines and tools are now available, so the system is also very versatile.
The zebrafish is therefore likely to be a successful infection model to
delineate the host-pathogen interactions that lead to mycobacterial
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SUPPLEMENTARY MATERIAL
Supplementary material for this article is available at
http://dmm.biologists.org/lookup/suppl/doi:10.1242/dmm.006676/-/DC1
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